Francesco Lanfranchi

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Venues

Cancers

Expert review of medical devices

This page only lists publications with an associated author ORCID identifier.

Publications

Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Matteo Bauckneht, Francesco Lanfranchi, Silvia Morbelli, Anna Giulia Nappi, Cristina Ferrari, Giuseppe Rubini, Stefano Panareo, Luca Urso, Mirco Bartolomei, Davide D'Arienzo, Tullio Valente, Virginia Rossetti, Paola Caroli, Federica Matteucci, Demetrio Aricò, Michelangelo Bombaci, Domenica Caponnetto, Francesco Bertagna, Domenico Albano, Francesco Dondi, Sara Gusella, Alessandro Spimpolo, Cinzia Carriere, Michele Balma, Ambra Buschiazzo, Rosj Gallicchio, Giovanni Storto, Livia Ruffini, Veronica Cervati, Roberta Eufrasia Ledda, Anna Rita Cervino, Lea Cuppari, Marta Burei, Giuseppe Trifirò, Elisabetta Brugola, Carolina Arianna Zanini, Alessandra Alessi, Valentina Fuoco, Ettore Seregni, Desiree' Deandreis, Virginia Liberini, Antonino Maria Moreci, Salvatore Ialuna, Sabina Pulizzi, Maria Luisa De Rimini
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. Cancers 15 (3) (2023)
Luca Urso, Matteo Bauckneht, Domenico Albano, Sotirios Chondrogiannis, Gaia Grassetto, Francesco Lanfranchi, Francesco Dondi, Giuseppe Fornarini, Massimo Lazzeri, Laura Evangelista
The evolution of PET imaging in renal, bladder, upper urinary tract urothelial, testicular and penile carcinoma - Today's impact, tomorrow's potential. Expert review of medical devices (2023)
Cecilia Marini, Vanessa Cossu, Francesco Lanfranchi, Sonia Carta, Francesca Vitale, Francesca D'Amico, Matteo Bauckneht, Silvia Morbelli, Maria Isabella Donegani, Silvia Chiola, Stefano Raffa, Luca Sofia, Tania Di Raimondo, Filippo Ballerini, Chiara Ghiggi, Paolo Durando, Silvia Ravera, Mattia Riondato, Anna Maria Orengo, Silvia Bruno, Sabrina Chiesa, Gianmario Sambuceti
Divergent Oxidative Stress in Normal Tissues and Inflammatory Cells in Hodgkin and Non-Hodgkin Lymphoma. Cancers 15 (13) (2023)
Laura Evangelista, Andrea Bianchi, Alessio Annovazzi, Rosa Sciuto, Silvia Di Traglia, Matteo Bauckneht, Francesco Lanfranchi, Silvia Morbelli, Anna Giulia Nappi, Cristina Ferrari, Giuseppe Rubini, Stefano Panareo, Luca Urso, Mirco Bartolomei, Davide D'Arienzo, Tullio Valente, Virginia Rossetti, Paola Caroli, Federica Matteucci, Demetrio Aricò, Michelangelo Bombaci, Domenica Caponnetto, Francesco Bertagna, Domenico Albano, Francesco Dondi, Sara Gusella, Alessandro Spimpolo, Cinzia Carriere, Michele Balma, Ambra Buschiazzo, Rosj Gallicchio, Giovanni Storto, Livia Ruffini, Veronica Cervati, Roberta Eufrasia Ledda, Anna Rita Cervino, Lea Cuppari, Marta Burei, Giuseppe Trifirò, Elisabetta Brugola, Carolina Arianna Zanini, Alessandra Alessi, Valentina Fuoco, Ettore Seregni, Desiree' Deandreis, Virginia Liberini, Antonino Maria Moreci, Salvatore Ialuna, Sabina Pulizzi, Maria Luisa De Rimini
ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors. Cancers 15 (3) (2023)
Francesco Lanfranchi, Sara Maggio, Carlo Delucchi, Francesca Bertoldi, Ferdinando Corica, Maria Silvia De Feo, Cecilia Marini, Teresita Aloè, Viviana Frantellizzi, Giuseppe De Vincentis, Silvia Morbelli, Gianmario Sambuceti, Emanuela Barisione, Matteo Bauckneht
The added value of lung perfusion scintigraphy semiquantitative measures in post-COVID patients with persistent dyspnea without pulmonary embolism. Expert review of medical devices (2023)
Matteo Bauckneht, Carlo Genova, Giovanni Rossi, Erika Rijavec, Maria Giovanna Dal Bello, Giulia Ferrarazzo, Marco Tagliamento, Maria Isabella Donegani, Federica Biello, Silvia Chiola, Lodovica Zullo, Stefano Raffa, Francesco Lanfranchi, Giuseppe Cittadini, Cecilia Marini, Egesta Lopci, Gianmario Sambuceti, Francesco Grossi, Silvia Morbelli
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab. Cancers 13 (13) (2021)

Francesco Lanfranchi.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Francesco Lanfranchi